Cresset Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,148
Closed -$699K 2188
2024
Q1
$699K Buy
2,148
+224
+12% +$55K ﹤0.01% 1167
2023
Q4
$367K Buy
1,924
+43
+2% +$8.13K ﹤0.01% 1393
2023
Q3
$375K Buy
1,881
+124
+7% +$29.3K ﹤0.01% 1330
2023
Q2
$501K Buy
+1,757
New +$488K ﹤0.01% 1283

Other funds holding SWAV

Cresset Asset Management's SWAV Position: Q2 2024 in Review

Cresset Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 2,148 shares — an estimated $699K sold.

Cresset Asset Management first reported a position in SWAV in Q2 2023 and held it in 4 quarters. The position peaked at $699K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Cresset Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Cresset Asset Management sold 2,148 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $699K.
  • Cresset Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • Cresset Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $699K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Cresset Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.